Related Experiment Video
Updated: Jun 22, 2026
16:56
Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
Published on: August 30, 2014
New applications for sublingual immunotherapy in allergy
Cristoforo Incorvaia1, Marina Mauro, Tiziana Cappelletti
1Allergy/Pulmonary Rehabilitation, ICP Hospital, Milan, Italy. cristoforo.incorvaia@gmail.com
Recent Patents on Inflammation & Allergy Drug Discovery
|June 13, 2009
Summary
Sublingual immunotherapy (SLIT) offers a safer alternative to traditional injections for allergies. It effectively treats allergic rhinitis, asthma, and shows promise for food, latex allergies, and atopic dermatitis.
Area of Science:
- Immunology
- Allergology
- Pharmacology
Background:
- Specific immunotherapy targets the root causes of allergic diseases, unlike symptom-focused treatments.
- Sublingual immunotherapy (SLIT) was developed to mitigate adverse reactions associated with subcutaneous immunotherapy (SCIT).
Purpose of the Study:
- To review the efficacy and safety of SLIT for various allergic conditions.
- To explore emerging applications of SLIT beyond traditional allergic rhinitis and asthma.
Main Methods:
- Review of placebo-controlled trials and existing literature on SLIT efficacy and safety.
- Analysis of SLIT application in food allergy, latex allergy, atopic dermatitis, and baker's asthma.
Main Results:
- SLIT demonstrates efficacy in treating allergic rhinitis and asthma due to pollens and house dust mites.
- Evidence supports SLIT's efficacy and safety in patients with latex and food allergies.
- Placebo-controlled trials indicate positive outcomes for SLIT in children with atopic dermatitis.
Conclusions:
- SLIT is a viable treatment option for allergic rhinitis, asthma, food allergies, latex allergies, and atopic dermatitis.
- SLIT presents a safer alternative for allergies where SCIT is less feasible due to safety concerns.
- The article also touches upon patents within the field of specific immunotherapy.
Related Concept Videos
02:06Allergic Reactions
Overview
01:22Drug Delivery: Miscellaneous Routes
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...